Evidence map›Paper›PMID 34325832›Full record

ArticleJournal of the American College of Cardiology2021

The Residual Risk Odyssey: From LDL to Lp(a).

Robert S Rosenson, Sascha N Goonewardena

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Journal of the American College of Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Lipoprotein(a): a Case for Universal Screening in Youth.Current atherosclerosis reports · 2023
    Review
  5. Role of lipoprotein(a) in plaque progression.European heart journal supplements : journal of the European Society of Cardiology · 2022
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Robert S RosensonMetabolism and Lipids Unit, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Icahn School of Medicine, New York, New York, USA. Electronic address: robert.rosenson@mssm.edu.
Sascha N GoonewardenaFrankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Proprotein Convertase 9Cholesterol, LDLHumansCholesterol, LDLProprotein Convertase 9acute coronary syndromelipoprotein(a)low-density lipoprotein cholesterolPCSK9 inhibitor

Identifiers

PMID34325832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.